Walgreens Boots Alliance (WBA) PT Raised to $71.00 at Robert W. Baird

Share on StockTwits

Walgreens Boots Alliance (NASDAQ:WBA) had its price objective boosted by investment analysts at Robert W. Baird from $69.00 to $71.00 in a research report issued on Friday, Stock Target Advisor reports. The brokerage currently has a “neutral” rating on the pharmacy operator’s stock. Robert W. Baird’s price objective would suggest a potential downside of 3.40% from the company’s current price.

Several other equities analysts have also recently issued reports on WBA. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Friday, June 22nd. Cowen cut shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 target price on the stock. in a research note on Monday, July 23rd. TheStreet upgraded shares of Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research note on Wednesday, September 12th. ValuEngine upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, September 21st. Finally, SunTrust Banks upped their target price on shares of Walgreens Boots Alliance to $75.00 and gave the company a “hold” rating in a research note on Friday. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $77.56.

Shares of Walgreens Boots Alliance stock opened at $73.50 on Friday. The stock has a market capitalization of $72.35 billion, a P/E ratio of 14.41, a PEG ratio of 1.11 and a beta of 1.04. Walgreens Boots Alliance has a 1 year low of $59.07 and a 1 year high of $80.68. The company has a current ratio of 0.93, a quick ratio of 0.47 and a debt-to-equity ratio of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. The company had revenue of $33.44 billion for the quarter, compared to analysts’ expectations of $33.64 billion. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. As a group, analysts expect that Walgreens Boots Alliance will post 5.98 earnings per share for the current fiscal year.

In other Walgreens Boots Alliance news, COO Ornella Barra acquired 1,700,000 shares of the stock in a transaction dated Monday, July 16th. The shares were purchased at an average price of $65.15 per share, for a total transaction of $110,755,000.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the completion of the transaction, the director now owns 10,943 shares in the company, valued at approximately $722,128.57. The disclosure for this sale can be found here. 14.80% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in WBA. BlueMountain Capital Management LLC purchased a new stake in Walgreens Boots Alliance in the 2nd quarter worth approximately $103,000. CSat Investment Advisory L.P. purchased a new stake in Walgreens Boots Alliance in the 2nd quarter worth approximately $104,000. Squar Milner Financial Services LLC purchased a new stake in Walgreens Boots Alliance in the 2nd quarter worth approximately $106,000. Kaizen Advisory LLC increased its holdings in Walgreens Boots Alliance by 128.6% in the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after acquiring an additional 1,083 shares in the last quarter. Finally, Camarda Financial Advisors LLC purchased a new stake in Walgreens Boots Alliance in the 2nd quarter worth approximately $137,000. 61.92% of the stock is owned by institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Read More: Average Daily Trade Volume – What You Need to Know

Stock Target Advisor

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply